1. Home
  2. PRFX vs HTCR Comparison

PRFX vs HTCR Comparison

Compare PRFX & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PainReform Ltd.

PRFX

PainReform Ltd.

N/A

Current Price

$0.63

Market Cap

2.6M

Sector

Health Care

ML Signal

N/A

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

N/A

Current Price

$1.60

Market Cap

2.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
PRFX
HTCR
Founded
2007
2009
Country
Israel
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
2.3M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
PRFX
HTCR
Price
$0.63
$1.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 55.4K
23.3K
Earning Date
09-03-2026
11-16-2026
Dividend Yield
N/A
★ 214.88%
EPS Growth
N/A
★ 414.29
EPS
★ N/A
N/A
Revenue
N/A
★ $30,407,229.00
Revenue This Year
N/A
$118.88
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 39.19
52 Week Low
$0.58
$1.15
52 Week High
$5.39
$10.43

Technical Indicators

Market Signals
Indicator
PRFX
HTCR
Relative Strength Index (RSI) 34.85 45.35
Support Level N/A $1.20
Resistance Level $1.25 $1.88
Average True Range (ATR) 0.10 0.17
MACD -0.01 0.00
Stochastic Oscillator 5.62 33.85

Price Performance

Historical Comparison
PRFX
HTCR

About PRFX PainReform Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.

Share on Social Networks: